Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer

Press/Media: Press / Media

Period	2018 Oct 2

Title Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer
Media name/outlet Clinical Trials.gov
Country United States
Date 18/10/2
Persons Byungha Chung

Title	Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer
Media name/outlet	Clinical Trials.gov
Country	United States
Date	18/10/2
Persons	Byungha Chung